PharVision Advisers’s Comcast CMCSA Stock Holding History

PharVision Advisers’s Portfolio CMCSA Stock Details CMCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,809	Closed	-$293K	–	211
2025 Q4	$293K	Buy	9,809 +629	+7%	+$17.9K	0.15%	285
2025 Q3	$288K	Buy	+9,180	New	+$308K	0.16%	249

Other funds holding CMCSA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PharVision Advisers's CMCSA Position: Q1 2026 in Review

PharVision Advisers sold out of Comcast (CMCSA) in Q1 2026, closing a stake of 9,809 shares — an estimated $293K sold.

PharVision Advisers first reported a position in CMCSA in Q3 2025 and held it in 2 quarters. The position peaked at $293K in Q4 2025. 2,054 funds tracked by Wall St. Rank hold CMCSA as of Q1 2026.

PharVision Advisers reported no remaining Comcast position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 9,809 Comcast shares in Q1 2026, an estimated $293K.
PharVision Advisers first reported a position in Comcast in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Comcast position peaked at $293K in Q4 2025.
2,054 funds tracked by Wall St. Rank held Comcast as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.